HIPEC in ovarian cancer: Treatment of a new era or is it the end of the pipeline?
Abstract
Ovarian cancer is the leading cause of death from gynecological cancer in western countries. The absence of an effective screening program as well as specific symptoms, makes the diagnosis difficult and often made in advanced stages of the disease, in the presence of peritoneal dissemination. The complete cytoreduction of the disease and tumor sensitivity to systemic chemotherapy based on platinums, are the two main prognostic factors. However...
Paper Details
Title
HIPEC in ovarian cancer: Treatment of a new era or is it the end of the pipeline?
Published Date
Nov 1, 2015
Journal
Volume
139
Issue
2
Pages
363 - 368
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History